We used VEGF ELISA kit and HIF-1α and NFκB activation (Motif Binding) assays to determine whether EGCG could suppress HIF-1α and NFκB activation and VEGF expression in cultured mouse breast cancer (E0771) cells. This evidence concerns the gene HIF1A and breast cancer.